Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Qol Holdings Co., Ltd.. A complete text table follows the diagram.
Pharmaceutical revenue rose 42.7% and segment profit 47.4% on new authorized generics, while the much larger pharmacy business grew 3.2% but profit fell 4.3% as wages rose and prescription volumes declined.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Health insurance pharmacy | 1 | 86.7B | 61.0% of reported total |
| Pharmaceutical business | 1 | 48.4B | 34.1% of reported total |
| Medical related | 1 | 7.1B | 5.0% of reported total |
| Revenues From External Customers | 2 | 142.2B | Reported six-month total · ¥142.2B |
| Operating profit | 3 | 7.2B | 5.0% operating margin |
| Operating costs & expenses | 3 | 135.0B | Arithmetic residual to reported operating profit |
| Profit before tax | 4 | 7.1B | Reported pretax result |
| Operating profit | 4 | 41M | Generic pharmaceuticals are accelerating while the pharmacy network absorbs labor and reimbursement pressure. |
| Net profit attributable to owners | 5 | 3.5B | Reported parent-company result |
| Tax, attribution & other | 5 | 3.6B | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Health insurance pharmacy | Revenues From External Customers | 86.7B |
| Pharmaceutical business | Revenues From External Customers | 48.4B |
| Medical related | Revenues From External Customers | 7.1B |
| Revenues From External Customers | Operating profit | 7.2B |
| Revenues From External Customers | Operating costs & expenses | 135.0B |
| Operating profit | Profit before tax | 7.1B |
| Operating profit | Operating profit | 41M |
| Profit before tax | Net profit attributable to owners | 3.5B |
| Profit before tax | Tax, attribution & other | 3.6B |